Strength in numbers: The quest for asthma genes - 05/08/19
Key words : Genetic risk factors, childhood-onset asthma, adult-onset asthma
El texto completo de este artículo está disponible en PDF.
Disclosure of potential conflict of interest: D. Vercelli is currently supported by research grants from VIFOR/OM-Pharma, the National Institute of Allergy and Infectious Diseases, and the National Heart, Lung, and Blood Institute and previously received research support from Johnson & Johnson. E. R. Bleecker has undertaken clinical trials through his employers, Wake Forest School of Medicine and the University of Arizona, for AstraZeneca, MedImmune, Boehringer Ingelheim, Genentech, Novartis, Regeneron, and Sanofi Genzyme and has served as a paid consultant for ALK-Abelló, AstraZeneca, GlaxoSmithKline, MedImmune, Novartis, Regeneron, Sanofi Genzyme, and TEVA. |
Vol 144 - N° 2
P. 413-415 - août 2019 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?